unknown
Stage
2019
Founded
1
Investors
About
Dreamfold develops a generative protein design platform that applies machine learning to design safer, more effective antibody and protein therapeutics, with early wet‑lab validation aimed at reducing toxicity and improving efficacy in challenging diseases.
Explore Dreamfold's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.